- Profiling Reactive Metabolites via Chemical Trapping and Targeted Mass Spectrometry
- Does the brain listen to the gut?
- (Meta)genomic insights into the pathogenome of Cellulosimicrobium cellulans
- A robust adaptive denoising framework for real-time artifact removal in scalp EEG measurements
- Imputing Gene Expression in Uncollected Tissues Within and Beyond GTEx
- Small Rad51 and Dmc1 Complexes Often Co-occupy Both Ends of a Meiotic DNA Double Strand Break
- Controlling the Cyanobacterial Clock by Synthetically Rewiring Metabolism
- Choosing experiments to accelerate collective discovery
Of all the possible experiments available in biomedical research, only a small subset are ever tackled by scientists. This is in part due to institutional and cultural pressures that lead researchers to avoid risk-taking and choose inefficient research strategies, according to a new study based on a computational analysis of millions of patents and research articles. Despite increased opportunities for groundbreaking experiments, most scientists choose conservative research strategies to reduce personal risk, which makes collective discovery slower and more expensive, conclude Andrey Rzhetsky, PhD, professor of medicine and human genetics and director of the Conte Center for Computational Neuropsychiatric Genomics, and his colleagues.
Two distinguished scientists and educators have been named fellows of the American Association for the Advancement of Science (AAAS) for their scientifically or socially distinguished efforts to advance science or its applications. The latest University of Chicago additions are Barry Aprison, PhD, a senior lecturer in the Biological Sciences Collegiate Division and education and outreach director for the Institute for Genomics and Systems Biology, and Michael W. Vannier, MD, professor emeritus of radiology.
IGSB Alumnus Honored; Ron Hause has been awarded the prize for his work on protein quantitative trait loci with Drs. White, Dolan and Jones.
Every year, Popular Science honors the 10 brightest young minds that are reshaping science and the world.
IGSB’s Jack Gilbert was named in the top 10, highlighting his work profiling microbiomes, for his energy and enthusiasm as well as his love for Ice Cream.
In a recently published letter to Nature Biotechnology, Lixia Yao, IGSB core faculty Andrey Rzhetsky and colleagues dissect the decisions made in funding choices. His team compares these choices by funding agencies to trades in a financial market. In this communication, they expand on the idea that there exists an imbalance between health needs and biomedical research investment.